Additional Information

Description

Tadalafil + Apomorphine Troches 22 mg/2 mg is a compounded formulation used for the treatment of erectile dysfunction (ED) and hypoactive sexual desire disorder (HSDD). It combines tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, with apomorphine, a dopamine receptor agonist. This dual mechanism targets both vascular and neurochemical pathways involved in sexual function.

The troche is administered by placing it in the mouth and allowing it to fully dissolve, typically about 30 minutes before anticipated sexual activity. This route of administration ensures rapid absorption and onset of action. Food and drink should be avoided for a period before and after use to enhance effectiveness and absorption consistency.

Adverse effects may include hypotension, dizziness, headache, nausea, and somnolence. Apomorphine carries a risk of impulse control disorders, and patients should be monitored for unusual behaviors or mood changes. Both active ingredients can impact blood pressure and central nervous system function, requiring caution in patients with cardiovascular or neuropsychiatric conditions.